Are you Dr. Chand?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 30 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
2013 Jefferson St Sw
Second Floor
Roanoke, VA 24014Phone+1 540-982-0237Fax+1 540-982-0103
Summary
- Dr. Vikram Chand, MD is an oncologist in Roanoke, Virginia. He is currently licensed to practice medicine in Virginia, Connecticut, and Iowa.
Education & Training
- University Iowa Affiliated HospitalsFellowship, Hematology and Medical Oncology, 2002 - 2004
- St Elizabeth's Medical CenterFellowship, Hematology and Medical Oncology, 1996 - 1997
- Gundersen Lutheran Medical FoundationResidency, Internal Medicine, 1993 - 1996
- Maulana Azad Medical CollegeClass of 1991
Certifications & Licensure
- VA State Medical License 2006 - 2026
- CT State Medical License 2010 - 2025
- WI State Medical License 1995 - 2025
- IA State Medical License 2001 - 2018
Publications & Presentations
PubMed
- 416 citationsDurvalumab With or Without Tremelimumab vs Standard Chemotherapy in First-line Treatment of Metastatic Non–Small Cell Lung Cancer: The MYSTIC Phase 3 Randomized Clinic...Naiyer A. Rizvi, Byoung Chul Cho, Niels Reinmuth, Ki Hyeong Lee, Alexander Luft
JAMA Oncology. 2020-05-01 - 306 citationsAfatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phas...Jean-Charles Soria, Enriqueta Felip, Manuel Cobo, Shun Lu, Konstantinos N. Syrigos
The Lancet. Oncology. 2015-08-01 - 65 citationsAvelumab (anti-PD-L1) as first-line switch-maintenance or second-line therapy in patients with advanced gastric or gastroesophageal junction cancer: Phase 1b results f...Hyun Cheol Chung, Hendrik Tobias Arkenau, Jeeyun Lee, Sun Young Rha, Do Youn Oh
Journal for Immunotherapy of Cancer. 2019-02-04